检索

期
标题
作者
卷 27, 编号 13 (2020)
Safety issues of antiplatelet and anticoagulant therapy in cardiological practice
Vorobyeva N., Tkacheva O.
PDF
(Rus)
卷 30, 编号 11 (2023)
Venous thrombosis and malignant gynecological diseases: the place of direct oral anticoagulants in prevention
Ulrikh E.
PDF
(Rus)
卷 31, 编号 1 (2024)
On the possible relationship between the presence of polymorphic variants of CYP3A4/5 cytochrome genes, their metabolic activity with rivaroxaban pharmacokinetics and the development of bleeding in patients with non-valvular atrial fibrillation and chronic kidney disease
Shatalova N., Mirzaev K., Abdullaev S., Sozaeva Z., Bochkov P., Asoskova A., Denisenko N., Kochetkov A., Ebzeeva E., Chernyaeva M., Shastina V., Ostroumova O., Sychev D.
PDF
(Rus)
卷 29, 编号 13 (2022)
Structure of prescription of gastroprotective drugs in patients receiving direct oral anticoagulants: results of a multicenter cross-sectional pharmacoepidemiological study
Ostroumova O., Orlova I., Kochetkov A., Polyakova O., Listratov A., Shatalova N., Batyukina S.
PDF
(Rus)
编号 13 (2015)
Effektivnost' i bezopasnost' vtorichnoy profilaktiki ishemicheskogo insul'ta antitrombotsitarnymi preparatami i peroral'nymi antikoagulyantami
Kamchatnov P., Evzel'man M., Evgrafov I.
PDF
(Rus)
编号 18-19 (2010)
NEW ORAL ANTICOAGULANTS (LITERATURE REVIEW)
Horev N., Momot A., Zalozniy D., Khorev N., Momot A., Zaloznyy D.
卷 30, 编号 14 (2023)
Therapeutic horizons of indirect oral anticoagulants
Zakharov S., Savchenko A.
PDF
(Rus)
卷 27, 编号 14 (2020)
Scientific rationale and prerequisites for the use of direct oral anticoagulants for the prevention of thromboembolic complications in patients with COVID-19
Otdelenov V., Matveev A., Mirzaev K., Sychev D.
PDF
(Rus)
编号 13 (2014)
Novye oral'nye antikoagulyanty v profilaktike i lechenii venoznykh trombozov i tromboemboliy: fokus na rivaroksaban
Glezer M.
PDF
(Rus)
编号 10 (2009)
Current principles of management of patients experienced acute cerebral circulation disorder at out-patient stage
Tanashyan M., Domashenko M., Tanasjn M., Domashenko M.
卷 30, 编号 12 (2023)
Consumption of oral anticoagulants in hospitals of the Russian Federation: analysis of the dynamics of procurement data
Matveev A., Glagoleva S., Sychev D.
PDF
(Rus)
编号 9 (2014)
PROFILAKTIKA TROMBOEMBOLIChESKIKh OSLOZhNENIY U PATsIENTOV S FIBRILLYaTsIEY PREDSERDIY
Morozova T., Andrushchishina T.
PDF
(Rus)
卷 27, 编号 4 (2020)
Medicines associated with the development of osteoporosis
Ostroumova O., Goloborodova I.
PDF
(Rus)
编号 6 (2014)
Sovremennye vozmozhnosti profilaktiki insul'tov u bol'nykh fibrillyatsiey predserdiy
Baryshnikova G.
PDF
(Rus)
卷 30, 编号 9/10 (2023)
Treatment and secondary prevention of venous thromboembolic complications: positions of apixaban
Vorobyeva N., Tkacheva O.
PDF
(Rus)
卷 27, 编号 2 (2020)
Drug-induced colitis
Livzan M., Gaus O., Nikolaev N.
PDF
(Rus)
编号 10 (2013)
Preduprezhdenie tromboembolii u bol'nykh fibrillyatsiey predserdiy
Kanorskiy S.
PDF
(Rus)
卷 32, 编号 1 (2025)
Anticoagulant therapy in elderly patients with atrial fibrillation and atrial flutter: the position of rivaroxaban
Zakiev V.
PDF
(Rus)
卷 30, 编号 1/2 (2023)
Modern principles of antiarrhythmic therapy of atrial fibrillation
Tarzimanova A.
PDF
(Rus)
编号 9 (2017)
RISK FACTORS FOR CEREBROVASCULAR DISEASES IN NEUROGERIATRY
Novikova L., Akopyan A., Mustafin K., Khabibrakhmanova N., Kayumova I.
PDF
(Rus)
编号 14 (2012)
Vtorichnaya medikamentoznaya profilaktika ishemicheskogo insul'ta
Domashenko M., Maksimova M., Tanashyan M.
PDF
(Rus)
卷 31, 编号 7 (2024)
Modern methods of thrombosis prevention and treatment in cancer patients with atrial fibrillation: focus on apixaban
Rubanenko O., Zolotovskaya I., Shatskaya P.
PDF
(Rus)
卷 30, 编号 1/2 (2023)
Atrial fibrillation and anemia: what do we know and how to approach therapy?
Polyakova O., Dubinina A., Telkova S., Isaakyan Y., Ostroumova O.
PDF
(Rus)
编号 13 (2016)
ANTICOAGULATION WITH DIRECT ORAL ANTICOAGULANTS BEYOND CLINICAL RECOMMENDATIONS: DIFFICULT CHOICE OF CLINICIANS AND PERSONALIZED APPROACH TO TREATMENT
Napalkov D., Sokolova A.
PDF
(Rus)
编号 15 (2011)
DABIGATRAN: PROSPECTS FOR CLINICAL APPLICATION
Zateyshchikov D., Zotova I., Zateyshcikov D., Zotova I.
卷 31, 编号 4 (2024)
Safety of direct oral anticoagulants in the treatment of atrial fibrillation in geriatric patients: focus on clinically relevant non-major bleeding
Sychev D., Cherniaeva M., Rozhkova M., Moiseeva E., Pogodina A., Bayzel Y., Egorova L., Maslennikova O., Lomakin N.
PDF
(Rus)
卷 29, 编号 13 (2022)
Nadroparin in the treatment of unstable angina and myocardial infarction: a point of view of a clinical pharmacologist
Mubarakshina O., Somova M., Batishcheva G.
PDF
(Rus)
编号 6 (2016)
MANAGEMENT OF PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE SETTINGS OF ANTICOAGULANT THERAPY CONTROL OFFICE: PROLONGED EFFECTIVE AND SAFE USE OF ANTICOAGULATION
Sokolova A., Tsarev I., Napalkov D., Sulimov V.
PDF
(Rus)
编号 14 (2011)
INTRACRANIAL HEMORRHAGIC COMPLICATIONS AGAINST THE BACKGROUND OF USE OF INDIRECT ANTICOAGULANTS
Dankovtseva E., Arkhipov S., Zateyshchikov D., Dankovceva E., Arhipov S., Zateyshikov D.
1 - 29 的 29 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语